MBBS
Relugolix 120 mg (raxigo) tablets
How It Works
Relugolix, marketed under the brand name Raxigo, is a medication used for the treatment of prostate cancer and uterine fibroids. It works by inhibiting the production of certain hormones, specifically luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are involved in the growth and progression of these conditions. By suppressing LH and FSH levels, Relugolix helps to decrease the production of testosterone in men and estrogen in women, which slows down the growth of prostate cancer cells and fibroids, respectively.
Side Effects
- Hot flashes
- Fatigue
- Nausea
- Decreased libido
- Diarrhea
- Increased levels of liver enzymes
Indications
- Raxigo is indicated for the treatment of:
- Prostate cancer
- Uterine fibroids
Contraindications
- Hypersensitivity to relugolix or any component of the formulation
- Pregnancy (due to potential harm to the fetus)
- Severe liver impairment
- History of cardiovascular events
Price Comparison in Different Countries
| Country | Price (per tablet) | Website |
|---|---|---|
| United States | $30 | GoodRx |
| United Kingdom | £25 | NHS |
| Australia | AUD 40 | Chemist Warehouse |
| Canada | CAD 35 | Canada Drugs Direct |
| Germany | €28 | Apotheken Umschau |
Top 5 Global Brands
- Myovant Sciences
- Astellas Pharma
- Takeda Pharmaceutical Company
- AbbVie
- Sumitomo Dainippon Pharma
One of the following licensed pharmacy from the nearest location will deliver Relugolix 120 mg (raxigo) tablets. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Reviews
There are no reviews yet.